Tailored Therapy for Chronic Myeloid Leukaemia
Published 12 December 2019 Chronic myeloid leukaemia (CML) is a slowly progressing form of blood cancer that attacks the blood-forming cells in the bone marrow. The condition requires lifelong treatment that can cause severe side effects. Rebecca Warfvinge maps stem cells in patients in the hope of identifying predictive markers for how the patient will react to therapy. She has now received an aw
https://www.lucc.lu.se/article/tailored-therapy-chronic-myeloid-leukaemia - 2025-01-17